tiprankstipranks
Trending News
More News >
Bioxcel Therapeutics Inc (BTAI)
NASDAQ:BTAI

Compare Bioxcel Therapeutics (BTAI) vs. Competitors

Compare
1,918 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Bioxcel Therapeutics
$1.58
$34.77M
-0.16
-69.71%
0 Buy
0 Hold
1 Sell
Moderate Sell
Actinium Pharmaceuticals
$1.16
$36.19M
-1.10
5.17%
3 Buy
0 Hold
0 Sell
Strong Buy
Kezar Life Sciences
$6.19
$44.45M
-0.72
-5.56%
Annovis Bio
$2.70
$71.56M
-1.82
-44.56%
2 Buy
0 Hold
0 Sell
Moderate Buy
BioAtla
$0.27
$17.23M
-0.15
-63.19%
2 Buy
0 Hold
0 Sell
Moderate Buy
Century Therapeutics
$1.90
$166.07M
-5.92
124.39%
2 Buy
1 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
BTAI
Bioxcel Therapeutics
1.58
-3.34
-67.89%
ATNM
Actinium Pharmaceuticals
1.22
0.04
3.39%
KZR
Kezar Life Sciences
6.12
-0.10
-1.61%
ANVS
Annovis Bio
2.70
-0.54
-16.67%
BCAB
BioAtla
0.17
-0.28
-61.89%
IPSC
Century Therapeutics
1.84
1.06
135.90%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts